Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5866646

Cc1cc(COc2ccc(C(=O)N[C@@H]3CNC[C@H]3c3n[nH]c(=S)[nH]3)cc2)c2ccccc2n1.O=C(O)C(F)(F)F

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.61
MMP12 P39900 2/20 0.57
MMP7 P09237 1/20 0.57
MMP13 P45452 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5866624 1.00 ADAM17 (0.61) ADAM17MMP12MMP7MMP13
Trifluoroacetic Acid SCHEMBL5866645 1.00 ADAM17 (0.61) ADAM17MMP12MMP7MMP13
Trifluoroacetic Acid SCHEMBL5866683 1.00 ADAM17 (0.61) ADAM17MMP12MMP7MMP13
SCHEMBL5866634 0.96 ADAM17 (0.67) ADAM17MMP12MMP7MMP13
SCHEMBL5866676 0.96 ADAM17 (0.67) ADAM17MMP12MMP7MMP13
SCHEMBL5866641 0.96 ADAM17 (0.67) ADAM17MMP12MMP7MMP13
SCHEMBL5248676 0.96 ADAM17 (0.67) ADAM17MMP12MMP7MMP13
Trifluoroacetic Acid SCHEMBL5866704 0.94 ADAM17 (0.58) ADAM17MMP12MMP7MMP13
Trifluoroacetic Acid SCHEMBL5866703 0.94 ADAM17 (0.58) ADAM17MMP12MMP7MMP13
Trifluoroacetic Acid SCHEMBL5866663 0.94 ADAM17 (0.58) ADAM17MMP12MMP7MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074810-B2 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme BRISTOL-MYERS SQUIBB COMPANY (US) 2006-07-11 US disclosed
US-20040116491-A1 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme BRISTOL-MYERS SQUIBB COMPANY 2004-06-17 US disclosed